+65.3%
GSK vs VCLT
+14.4%
+50.9%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VCLT | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -0.4% | +0.9% | +0.8% |
| 7D | +1.1% | -2.3% | +3.4% | +2.6% |
| 30D | +6.3% | +0.8% | +5.6% | +5.9% |
| 3M | +1.8% | -2.7% | +4.5% | +3.6% |
| 6M | +1.7% | -4.3% | +5.9% | +4.5% |
| YTD | +6.5% | -4.3% | +10.9% | +9.6% |
| 1Y | +9.5% | -4.4% | +13.8% | +12.7% |
| 3Y | +65.3% | +13.8% | +51.5% | +69.8% |
| All | +65.3% | +14.4% | +50.9% | +69.8% |
Cumulative growth
Daily Returns
Daily percentage return beside VCLT.
Daily Out/Under-Performance
Portfolio return minus VCLT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VCLT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VCLT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling